Cytodyn Inc (CYDY)

[Biotech Investor]

I'm making preparations to enjoy a delicious steak dinner with an equisite glass of fine red wine (or two). The day is getting closer to hold being lifted. I anticipate share price quickly moving up to $1-$2 range in near future and achieving $5 target price over the next 6-12 months as events unfold. Much higher later as the potential of Leronlimab is realized. Merck will partner with Cytodyn IMO and combine Keytruda and Leronlimab for Cancer. It's a winning combination and the revenue potential is enormous. I'm looking forward to the study results of Keytruda and Leronlimab at MD Anderson being released. NASH potential is also huge. I'm also excited about the potential functional cure for HIV thanks to the amazing work of Jonah Sacha. He's an absolutely brilliant scientist. Congrats to all Cytodyn shareholders. The future looks bright and GREEN $$$$$ ! ?? ??to the shorts. Buckle up !